Get early access! Join the Twelve Data AI Assistant waitlist now.

HALO

65.13000 USD
1.09
1.70%
Last update Aug 13, 3:59 PM EDT
Market closed
Day range
63.64000
65.15000
Previous close
64.040001
Open
64.69000
Access this stock data via API
Subscribe
Halozyme Therapeutics Inc.
65.13
1.09
1.70%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 1.0B 829.3M 660.1M 443.3M
Cost of revenue 159.4M 192.4M 139.3M 81.4M
Gross profit 855.9M 636.9M 520.8M 361.9M
Operating expense
Research & development 79.0M 76.4M 66.6M 35.7M
Selling general and admin 154.3M 149.2M 143.5M 50.3M
Other operating expenses
Operating income 551.5M 337.6M 267.5M 275.9M
Non operating interest income
Income
Expense 18.1M 18.8M 16.9M 7.5M
Other income expense 23.8M 29.5M -1.7M -19.9M
Pretax income 557.1M 348.3M 248.9M 248.5M
Tax provision 113.0M 66.7M 46.8M -154.2M
Net income 444.1M 281.6M 202.1M 402.7M
Basic EPS 3.5 2.1 1.5 2.9
Diluted EPS 3.4 2.1 1.4 2.7
Basic average shares 126.8M 131.9M 136.8M 140.6M
Diluted average shares 126.8M 131.9M 136.8M 140.6M
EBITDA 632.8M 422.4M 317.2M 278.9M
Net income from continuing op. 444.1M 281.6M 202.1M 402.7M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 4 hours 50 minutes

23:09
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).